Genetics
Neurogenetics Tests in Dubai & UAE
Investigations in this area, with the specimen type, turnaround time and listed price for each option — so you and your clinician can compare before you book.
- Quality-controlled laboratory
- Home collection across the UAE
- Confidential handling of results
Compare options
Neurogenetics investigations
All 68 investigations in this category are listed below.
| Test | What it measures | Specimen | Turnaround | Price | Book |
|---|---|---|---|---|---|
| APP Gene Alzheimer Disease Type 1 Genetic Test TEST-3746 LOINC 21645-4 | This test detects pathogenic mutations in the APP gene associated with early-onset familial Alzheimer's disease. | Peripheral whole blood | 3–4 weeks | 2,800.00 AED | Details |
| APP Gene Cerebral Amyloid Angiopathy (CAA) Genetic Test TEST-3979 LOINC 81247-9 | This diagnostic test evaluates the entire APP gene for pathogenic variants associated with hereditary cerebral amyloid angiopathy (CAA) and familial A... | Peripheral Blood or Dried Blood Spot (FTA Card) | 3–4 Weeks | 2,800.00 AED | Details |
| AR Gene Spinal & Bulbar Muscular Atrophy (SBMA) Genetic Test TEST-5820 LOINC 21636-6 | This genetic test evaluates the androgen receptor (AR) gene for CAG trinucleotide repeat expansions, which are the cause of Spinal and Bulbar Muscular... | Peripheral Whole Blood or FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| ARHGEF10 Gene Slowed Nerve Conduction Velocity, Autosomal Dominant Genetic Test TEST-5693 LOINC 51966-3 | This test identifies pathogenic variants in the ARHGEF10 gene, which are responsible for autosomal dominant slowed nerve conduction velocity neuropath... | Peripheral whole blood (5 mL EDTA), extracted DNA, or dried blood spot on FTA card | 3 to 4 weeks | 2,800.00 AED | Details |
| ARID1A Gene Sequencing (Mental Retardation, Autosomal Dominant Type 14) Genetic Test2,800 AED · 2026 DHA Guidelines Test TEST-4908 LOINC 21636-6 | This genetic test analyzes the ARID1A gene to identify pathogenic variants associated with Coffin-Siris syndrome, a neurodevelopmental disorder. | Peripheral whole blood (3–5 mL EDTA tube) | 3–4 weeks | 2,800.00 AED | Details |
| ARL13B Gene (Joubert Syndrome Type 8) Genetic Test TEST-4603 LOINC 83505-3 | This test identifies pathogenic variants in the ARL13B gene associated with Joubert syndrome type 8. | Whole Blood (Peripheral) – EDTA tube or FTA card | 3 – 4 Weeks | 2,800.00 AED | Details |
| ARX Gene Early Infantile Epileptic Encephalopathy Type 1 Genetic Test TEST-4276 LOINC 81306-1 | This genetic test identifies mutations in the ARX gene associated with Early Infantile Epileptic Encephalopathy Type 1 (EIEE1). | Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| ARX Gene Sequencing (Hydranencephaly with Abnormal Genitalia / X‑Linked Lissencephaly Type 2) Genetic Test TEST-4525 LOINC 21641-2 | This genetic test sequences the ARX gene to identify pathogenic variants associated with specific neurodevelopmental disorders. | Whole blood, extracted DNA, or one drop on FTA card | 3 to 4 weeks | 2,800.00 AED | Details |
| ASAH1 Gene Sequencing for Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME) Test TEST-5731 LOINC 81260-9 | This test detects pathogenic variants in the ASAH1 gene associated with Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME). | Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA | 3–4 Weeks | 2,800.00 AED | Details |
| Ataxin-10 (ATXN10) Gene Spinocerebellar Ataxia Type 10 Autosomal Dominant Genetic Test TEST-5741 LOINC 21636-6 | This genetic test identifies the specific pentanucleotide repeat expansion in the ATXN10 gene associated with Spinocerebellar Ataxia Type 10 (SCA10). | Whole blood (3–5 mL in EDTA), extracted DNA, or dried blood spot (FTA card) | 3–4 weeks | 2,800.00 AED | Details |
| ATP13A2 (PARK9) Gene Genetic Test TEST-5440 LOINC 81321-3 | This test evaluates the ATP13A2 gene for pathogenic variants associated with Kufor-Rakeb syndrome and early-onset Parkinson disease. | Peripheral Whole Blood | 3 to 4 Weeks | 2,800.00 AED | Details |
| BSCL2 Gene Test TEST-5470 LOINC 77669-8 | This test detects pathogenic variants in the BSCL2 gene associated with Distal Hereditary Motor Neuropathy Type 5A (dHMN5A). | Whole Blood (EDTA), Extracted DNA, or Buccal Swab / FTA Card | 10 to 14 Business Days | 2,800.00 AED | Details |
| C19orf12 Gene (SPG43) Genetic Test TEST-5762 LOINC 83402-5 | This test identifies pathogenic variants in the C19orf12 gene associated with autosomal recessive hereditary spastic paraplegia type 43 (SPG43). | Whole Blood (EDTA) or Dried Blood Spot (FTA Card) | 3 – 4 Weeks | 2,800.00 AED | Details |
| C9orf72 Gene Amyotrophic Lateral Sclerosis with Frontotemporal Dementia Genetic Test TEST-3795 LOINC 90520-1 | This test identifies pathological hexanucleotide repeat expansions in the C9orf72 gene, a primary genetic cause of familial ALS and FTD. | Peripheral whole blood | 3–4 Weeks (expedited option available) | 2,800.00 AED | Details |
| CASK Gene Genetic Test for Mental Retardation & Microcephaly with Pontocerebellar Hypoplasia TEST-4775 LOINC 81261-4 | This test identifies pathogenic variants in the CASK gene, which are associated with X-linked intellectual disability, microcephaly, and pontocerebell... | Peripheral whole blood (EDTA) or dried blood spot (FTA card) | 3 – 4 weeks from sample receipt | 2,800.00 AED | Details |
| CHMP2B Gene Amyotrophic Lateral Sclerosis Type 17 (ALS17) Genetic Test TEST-3778 LOINC 94845-8 | This genetic test identifies pathogenic variants in the CHMP2B gene associated with Amyotrophic Lateral Sclerosis Type 17 (ALS17). It confirms the mol... | Peripheral Whole Blood (3–5 mL in EDTA tube) or FTA Card DNA | 3–4 Weeks | 2,800.00 AED | Details |
| COASY Gene Neurodegeneration with Brain Iron Accumulation Type 6 Genetic Test TEST-5406 LOINC 21635-8 | This genetic test identifies pathogenic variants in the COASY gene associated with Neurodegeneration with Brain Iron Accumulation Type 6 (NBIA6). | Whole Blood (EDTA), Extracted DNA (≥1 µg), or FTA Card spot | 3 – 4 Weeks | 2,800.00 AED | Details |
| CSF1R Gene Leukoencephalopathy (Diffuse Hereditary with Spheroids) Genetic Test TEST-4702 LOINC 94712-8 | This test evaluates the CSF1R gene for mutations associated with Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS/ALSP). It identifies path... | Peripheral whole blood (EDTA) | 3 to 4 weeks | 2,800.00 AED | Details |
| CYP2U1 Gene SPG56 Next‑Generation Sequencing (NGS) Genetic Test TEST-5785 LOINC 101342-4 | This test evaluates the CYP2U1 gene for pathogenic variants associated with autosomal recessive hereditary spastic paraplegia type 56 (SPG56). | Whole blood (EDTA), extracted DNA, or FTA card | 3–4 weeks | 2,800.00 AED | Details |
| DCTN1 Gene Neuronopathy Distal Hereditary Motor Type 7B (HMN7B) Genetic Test TEST-5462 LOINC 94059-9 | This test identifies pathogenic variants in the DCTN1 gene associated with Distal Hereditary Motor Neuropathy Type 7B (HMN7B). | Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) | 3-4 weeks | 2,800.00 AED | Details |
| DNAJC3 Gene-Related Combined Cerebellar and Peripheral Ataxia with Hearing Loss and Diabetes Mellitus Test TEST-3853 LOINC 81303-8 | This test detects pathogenic variants in the DNAJC3 gene, confirming a rare autosomal recessive syndrome characterized by cerebellar ataxia, periphera... | Whole Blood (peripheral) / Extracted DNA / Dried Blood Spot on FTA Card | 3–4 Weeks | 2,800.00 AED | Details |
| DRD4 Gene ADHD Genetic Test TEST-3842 LOINC 21665-8 | This test evaluates the entire coding region of the DRD4 gene for variants associated with ADHD susceptibility. | Whole blood, extracted DNA, or finger-prick FTA card | 3 to 4 weeks | 2,800.00 AED | Details |
| DRPLA (Dentatorubral-Pallidoluysian Atrophy) Gene Analysis Test TEST-1028 LOINC 90982-3 | This test detects the number of CAG repeats in the ATN1 gene to diagnose DRPLA. | Peripheral whole blood | 5 working days | 1,000.00 AED | Details |
| EEF2 Gene Spinocerebellar Ataxia Type 26 (SCA26) Autosomal Dominant Genetic Test TEST-5880 LOINC 21636-9 | This test identifies pathogenic variants in the EEF2 gene associated with Spinocerebellar Ataxia Type 26 (SCA26). It provides a definitive molecular d... | Whole blood (EDTA), extracted genomic DNA, or FTA card blood spot | 3–4 weeks | 2,800.00 AED | Details |
| EIF2B1 Gene Leukoencephalopathy with Vanishing White Matter Genetic Test TEST-4693 LOINC 94047-7 | This test sequences the EIF2B1 gene to identify mutations associated with Vanishing White Matter Disease (VWM), a rare leukodystrophy. | Peripheral whole blood (EDTA tube) | 3 – 4 weeks | 2,800.00 AED | Details |
| EIF2B3 Gene Leukoencephalopathy with Vanishing White Matter Genetic Test TEST-4697 LOINC 59078-9 | This test identifies pathogenic variants in the EIF2B3 gene associated with leukoencephalopathy with vanishing white matter (VWM). It uses Next-Genera... | Peripheral Whole Blood or Saliva (Oragene DNA Collection Kit) | 3–4 Weeks | 2,800.00 AED | Details |
| EN2 Gene Autism Spectrum Disorder Genetic Test TEST-3880 LOINC 55233-1 | This test evaluates the EN2 gene for pathogenic variants linked to autism spectrum disorder risk. | Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Buccal Swab | 21 Working Days | 2,800.00 AED | Details |
| EOMES Gene Neuronal Migration Disorder Genetic Test TEST-5351 LOINC 21636-6 | This genetic test evaluates the EOMES gene for pathogenic variants associated with neuronal migration disorders. | Whole Blood, Extracted DNA, or FTA Card Spot | 3–4 Weeks | 2,800.00 AED | Details |
| FXN Gene Friedreich Ataxia Genetic Test TEST-4496 LOINC 21779-6 | This test evaluates the FXN gene for mutations associated with Friedreich ataxia. | Peripheral Whole Blood (Venous Draw or Finger-Prick FTA Card) | 3–4 weeks | 2,800.00 AED | Details |
| GARS1 Gene Distal Hereditary Motor Neuropathy Type 5 (dHMN5) Genetic Test TEST-5457 LOINC 99269-5 | This test evaluates the GARS1 gene for pathogenic variants associated with Distal Hereditary Motor Neuropathy Type 5 (dHMN5). It identifies single nuc... | Whole Blood (1–4 mL in EDTA) or Buccal Swab | 3–4 Weeks | 2,800.00 AED | Details |
| GBA Gene Lewy Body Dementia Susceptibility Genetic Test TEST-4707 LOINC 48018-6 | This genetic test evaluates the GBA gene for mutations associated with an increased susceptibility to developing Lewy Body Dementia. | Whole Blood (EDTA, 4 mL), Extracted DNA (≥2 µg at ≥50 ng/µL), or Dried Blood Spot on FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| GJB1 Gene CMTX1 Genetic Test TEST-4067 LOINC 21636-7 | This test evaluates the GJB1 gene for pathogenic variants associated with X-linked Charcot-Marie-Tooth disease type 1. | Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) | 3 – 4 Weeks | 2,800.00 AED | Details |
| GRN-Associated Frontotemporal Dementia (FTD) Genetic Test TEST-4188 LOINC 94635-8 | This test evaluates the GRN gene for pathogenic variants associated with frontotemporal dementia. | Peripheral Whole Blood | 3 to 4 Weeks | 2,800.00 AED | Details |
| HINT1 Gene Neuromyotonia and Axonal Neuropathy, Autosomal Recessive Genetic Test TEST-5346 LOINC 21636-6 | This test evaluates the HINT1 gene for pathogenic variants associated with autosomal recessive neuromyotonia and axonal neuropathy. | Whole Blood (EDTA), Extracted DNA, or FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| HSPB1 Gene Neuronopathy Distal Hereditary Motor Neuropathy Type 2B Genetic Test TEST-5356 LOINC 82325-7 | This genetic test identifies pathogenic variants in the HSPB1 gene, confirming a diagnosis of distal hereditary motor neuropathy type 2B. | Whole Blood, Extracted DNA, or FTA Card (Peripheral Blood) | 3–4 Weeks | 2,800.00 AED | Details |
| HTT Gene Huntington Disease Genetic Test (NGS) TEST-4516 LOINC 21669-3 | This test evaluates the number of CAG trinucleotide repeats in the HTT gene to diagnose Huntington disease or assess genetic risk. | EDTA Whole Blood | 3–4 Weeks | 2,800.00 AED | Details |
| HUWE1 Gene Mental Retardation, X-Linked Syndromic, Turner Type Test TEST-2588 LOINC 81311-0 | This genetic test identifies pathogenic variants in the HUWE1 gene associated with X-linked syndromic intellectual disability (Turner type). It utiliz... | Peripheral whole blood (EDTA) | 3 to 4 weeks | 2,800.00 AED | Details |
| KAT6A Gene Intellectual Disability (Autosomal Dominant Type 32) NGS Test TEST-4836 LOINC 81261-6 | This diagnostic test evaluates the KAT6A gene for pathogenic variants associated with autosomal dominant intellectual disability type 32. | Whole Blood (EDTA) | 3–4 weeks | 2,800.00 AED | Details |
| KCNQ2 Genetic Test (Early Infantile Epileptic Encephalopathy Type 7) TEST-4288 LOINC 94231-0 | This test identifies pathogenic mutations in the KCNQ2 gene associated with early infantile epileptic encephalopathy type 7. | Peripheral Whole Blood or FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| MAPT Gene Testing for Frontotemporal Dementia (NGS) Test TEST-4143 LOINC 92821-5 | This test analyzes the MAPT gene for pathogenic mutations linked to frontotemporal lobar degeneration (FTLD-tau subtype). | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card | 3 – 4 Weeks | 2,800.00 AED | Details |
| MPZ Gene CMT2J Next‑Generation Sequencing (NGS) Genetic Test TEST-4077 LOINC 21636-6 | This genetic test identifies pathogenic variants in the MPZ gene, confirming a diagnosis of Charcot-Marie-Tooth disease type 2J (CMT2J). | Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) | 3–4 Weeks | 2,800.00 AED | Details |
| MPZ Gene DI‑CMTD Genetic Test TEST-4216 LOINC 81263-2 | This test detects mutations, including deep intronic and copy number variants, in the MPZ gene associated with Dominant Intermediate Charcot-Marie-Too... | Peripheral Whole Blood | 3–4 weeks | 2,800.00 AED | Details |
| MXRA5 Gene Autism Spectrum Genetic Test TEST-3855 LOINC 94219-6 | This test identifies pathogenic variants in the MXRA5 gene associated with autism spectrum disorder. | Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot | 3 to 4 Weeks | 2,800.00 AED | Details |
| NDST1 Gene Analysis (Intellectual Disability, Autosomal Recessive Type 46) Genetic Test TEST-4985 LOINC 82326-0 | This test identifies pathogenic variants in the NDST1 gene associated with autosomal recessive intellectual disability type 46. | Peripheral whole blood (3–5 mL in EDTA tube) or FTA card dried blood spot; extracted DNA accepted | 3–4 weeks | 2,800.00 AED | Details |
| NOTCH4 Gene Schizophrenia Genetic Test TEST-5671 LOINC 55233-1 | This test identifies pathogenic variants in the NOTCH4 gene associated with schizophrenia susceptibility. | Blood, Extracted DNA, or One-drop Blood on FTA Card | 3 to 4 weeks | 2,800.00 AED | Details |
| NTNG1 Gene Sequencing Test for Autism Spectrum Disorder (NGS) TEST-3900 LOINC 92821-0 | This diagnostic test evaluates the NTNG1 gene for pathogenic or likely pathogenic variants associated with Autism Spectrum Disorder (ASD). | Peripheral Whole Blood (EDTA) | 3 – 4 Weeks | 2,800.00 AED | Details |
| PANK2 Gene Pantothenate Kinase-Associated Neurodegeneration Genetic Test TEST-5499 LOINC 94233-2 | This test evaluates the PANK2 gene for pathogenic variants associated with Pantothenate Kinase-Associated Neurodegeneration (PKAN). It uses Next-Gener... | Whole Blood (EDTA) or FTA Card (Finger-Prick) | 3–4 Weeks | 2,800.00 AED | Details |
| PMP22 Gene CMT1E Genetic Test TEST-4059 LOINC 52765-0 | This test identifies point mutations in the PMP22 gene associated with Charcot-Marie-Tooth disease type 1E (CMT1E). | Peripheral whole blood (EDTA), extracted DNA, or FTA card specimen | 3–4 weeks | 2,800.00 AED | Details |
| PMP22 Gene Dejerine-Sottas Disease Genetic Test TEST-4182 LOINC 81246-0 | This genetic test analyzes the PMP22 gene for pathogenic variants associated with Dejerine-Sottas disease (HMSN type III). It uses NGS and CNV analysi... | Peripheral whole blood (EDTA), extracted DNA, or FTA card | 3–4 weeks from sample collection | 2,800.00 AED | Details |
| PNKP Gene Sequencing (Early Infantile Epileptic Encephalopathy Type 10) Test TEST-4221 LOINC 83592-4 | This test sequences the PNKP gene to identify mutations associated with Early Infantile Epileptic Encephalopathy Type 10 (EIEE10). It provides a defin... | Whole blood, extracted DNA, or FTA card | 3–4 weeks | 2,800.00 AED | Details |
| POLG2 Gene Progressive External Ophthalmoplegia Type 4 DNA Test TEST-5623 LOINC 21665-7 | This test evaluates the entire POLG2 gene for pathogenic variants associated with autosomal dominant progressive external ophthalmoplegia type 4. | Whole blood, extracted DNA, or FTA card | 21–28 working days | 2,800.00 AED | Details |
| RPL10 Gene (Autism Susceptibility, X‐Linked Intellectual Disability Type 5) Genetic Test TEST-3876 LOINC 100215-2 | This test identifies pathogenic variants in the RPL10 gene associated with X-linked intellectual disability type 5 and autism spectrum disorder. | Peripheral whole blood (EDTA) or buccal swab | 3–4 Weeks | 2,800.00 AED | Details |
| SACS Gene Spastic Ataxia Charlevoix-Saguenay Type (ARSACS) Genetic Test TEST-5608 LOINC 21636-6 | This genetic test analyzes the SACS gene for mutations associated with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). It identifi... | Whole Blood (EDTA) or FTA Card Specimen | 3–4 weeks from sample receipt | 2,800.00 AED | Details |
| SCA6 (Spinocerebellar Ataxia Type 6) Test TEST-3080 LOINC 83113-5 | This diagnostic test evaluates for CAG repeat expansions within the CACNA1A gene, which are characteristic of Spinocerebellar Ataxia Type 6. | Standard peripheral whole blood (4 mL EDTA) | 4–5 days (Sample collected by Tuesday 11 am; Report delivered by Saturday) | 750.00 AED | Details |
| SCN9A Gene Neuropathy (HSAN2) Genetic Test TEST-5475 LOINC 82939-0 | This genetic test identifies disease-causing variants in the SCN9A gene associated with Hereditary Sensory and Autonomic Neuropathy Type 2 (HSAN2). | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spots (FTA Cards) | 3–4 Weeks | 2,800.00 AED | Details |
| SMARCA4-Related Intellectual Disability (MRD16) Genetic Test TEST-4912 LOINC 81247-9 | This test detects genetic variants in the SMARCA4 gene associated with intellectual disability. | Peripheral whole blood | 3–4 Weeks | 2,800.00 AED | Details |
| SOX11 Gene Mental Retardation, Autosomal Dominant Type 27 Genetic Test TEST-4829 LOINC 92822-6 | This test identifies pathogenic variants within the SOX11 gene, which are associated with autosomal dominant intellectual disability type 27 (MRD27).... | Whole Blood (EDTA), Extracted DNA, or FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| SPG60 (WDR48 Gene) Genetic Test TEST-5694 LOINC 87808-4 | This test evaluates the WDR48 gene for pathogenic variants associated with autosomal recessive hereditary spastic paraplegia type 60 (SPG60). It detec... | Whole Blood (peripheral) | 3 to 4 Weeks | -1.00 AED | Details |
| SPG7 Gene Genetic Test TEST-5809 LOINC 55233-1 | This test analyzes the SPG7 gene for pathogenic variants associated with Hereditary Spastic Paraplegia type 7. | Whole blood (EDTA) | 3–4 weeks | 2,800.00 AED | Details |
| TARDBP Gene Amyotrophic Lateral Sclerosis Type 10 Genetic Test TEST-3792 LOINC 96231-1 | This test evaluates the TARDBP gene for pathogenic variants associated with Amyotrophic Lateral Sclerosis Type 10 (ALS10). It uses Next Generation Seq... | Peripheral Whole Blood | 3 to 4 Weeks | 2,800.00 AED | Details |
| TECR Gene Sequencing (Intellectual Disability, Autosomal Recessive Type 14) Test TEST-4855 LOINC 96669-4 | This test identifies pathogenic variants in the TECR gene associated with autosomal recessive intellectual disability type 14. | Whole blood, extracted DNA, or FTA card | 3–4 Weeks | 2,800.00 AED | Details |
| TMEM240 Gene Spinocerebellar Ataxia Type 21, Autosomal Dominant Genetic Test TEST-5767 LOINC 55233-1 | This test identifies pathogenic variants in the TMEM240 gene, the cause of autosomal dominant spinocerebellar ataxia type 21. | Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card) | 3–4 Weeks | 2,800.00 AED | Details |
| TUBB Gene Neurodevelopmental Disorder NGS Test TEST-5334 LOINC 92738-5 | This test evaluates the TUBB gene for variants associated with neurodevelopmental disorders and brain malformations. | Whole Blood (peripheral) | 3 to 4 Weeks | 2,800.00 AED | Details |
| TWNK Gene Infantile-Onset Spinocerebellar Ataxia (SCA) Genetic Test TEST-5815 LOINC 94217-3 | This genetic test identifies pathogenic variants within the TWNK gene associated with infantile-onset spinocerebellar ataxia. | Peripheral Whole Blood (1-2 mL) or FTA Card | 3–4 Weeks | 2,800.00 AED | Details |
| WDR45 Gene Neurodegeneration with Brain Iron Accumulation Type 5 (BPAN) Genetic Test TEST-5404 LOINC 82307-8 | This test identifies pathogenic variants in the WDR45 gene associated with Beta-Propeller Protein-Associated Neurodegeneration (BPAN), also known as N... | Whole Blood (EDTA), Extracted DNA, FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| WDR81 Gene Cerebellar Ataxia, Intellectual Disability, and Dysequilibrium Syndrome Type 2 (CAMRQ2) Genetic Test TEST-4016 LOINC 55233-1 | This genetic test identifies pathogenic variants within the WDR81 gene associated with Cerebellar Ataxia, Intellectual Disability, and Dysequilibrium... | Peripheral Whole Blood | 3–4 Weeks | 2,800.00 AED | Details |
| WWOX Gene NGS Test for Early Infantile Epileptic Encephalopathy Type 28 (EIEE28) TEST-4315 LOINC 81329-4 | This test identifies pathogenic variants in the WWOX gene associated with early infantile epileptic encephalopathy type 28 (EIEE28). It provides a def... | Peripheral whole blood (EDTA) or dried blood spot | 3–4 weeks | 2,800.00 AED | Details |
| ZDHHC9 Gene Sequencing (Mental Retardation, X‑Linked Syndromic, Raymond Type) Genetic Test TEST-5001 LOINC 21624-7 | This test evaluates the ZDHHC9 gene for pathogenic variants associated with X-linked syndromic mental retardation (Raymond type). | Whole Blood (EDTA) or Extracted DNA | 10–14 Business Days | 2,800.00 AED | Details |
Clinical overview
About Neurogenetics
Before your appointment
Preparation & sample collection
Follow the instructions you are given
Fasting, timing and medicine restrictions differ between investigations. The instructions for your specific request are confirmed when you book.
Bring your identification
A valid photo ID is required at collection so that your sample is matched correctly to your record.
Tell us about medicines
Prescription medicines, supplements and recent procedures can affect how an investigation is scheduled or interpreted — please mention them.
Ask before collection
If anything about preparation is unclear, contact us before your appointment. Preparation errors can affect reporting times.
Patient information
Frequently asked questions
Practical answers about Neurogenetics testing at DNA Labs UAE. This information is general and does not replace advice from your treating clinician.
How do I choose the right Neurogenetics test?
The correct investigation depends on what your clinician is trying to establish. Review the specimen type and turnaround time below, then confirm the choice with your treating doctor before booking.
What specimen is required?
Specimen requirements are listed for each investigation. If a request involves more than one sample type, our team will confirm what is needed at the time of booking.
Do you offer home sample collection in Dubai and the UAE?
Yes. Home collection can be arranged across Dubai and the wider UAE. Availability and appointment windows vary by location, so please confirm when you book.
How long do results take?
Turnaround depends on the investigation and the method used. The expected reporting time is confirmed with you before collection.
Is there anything I need to do before sample collection?
Some investigations require fasting, a specific collection time, or avoiding certain medicines or activities. Preparation details are shared when you book — please follow them and ask if anything is unclear.
How will I receive my report?
Reports are issued as secure digital documents and can be shared with your referring clinician on request. Please review results with a qualified clinician who can interpret them in context.
About this clinical information
The information on this Neurogenetics page describes laboratory investigations in general terms. It is written to help you understand what an investigation involves — it is not a diagnosis and it is not a substitute for advice from your treating clinician.
- Investigation names, specimen types and listed prices are reviewed against laboratory records.
- Preparation guidance is indicative — confirm test-specific instructions before collection.
- Content is updated when investigations, methods or reporting formats change.
- Results are released to the patient and, on request, shared with the referring clinician.
Medical disclaimer: This page is for general information and education only. It is not medical advice, diagnosis or treatment, and it does not replace a consultation with a qualified healthcare professional. Always seek the advice of your doctor or another qualified provider with any questions about a medical condition or before ordering a test.
We're here to help
Need help choosing a Neurogenetics test?
Tell us what your clinician has requested and we'll confirm availability, price, preparation and the most convenient collection option — including home collection in Dubai and across the UAE.
- Home collection available across the UAE
- Digital reports delivered securely
- Confidential handling of every request
Related areas